Science 37 Holdings Inc. (SNCE)
$5.75
$0.00 (0.00%)As on 22-Mar-2024 09:30EDT
Market cap
$35 Mln
Revenue (TTM)
$60 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-106 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
49.28
-
EV/EBITDA
0.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-20.6
-
Face value
--
-
Shares outstanding
6,028,170
5 Years Aggregate
CFO
$-190.18 Mln
EBITDA
$-192.35 Mln
Net Profit
$-240.38 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Science 37 Holdings (SNCE)
| 7.7 | 0.9 | 40.2 | -16.3 | -69.8 | -- | -- |
|
BSE Sensex*
| -10.4 | -1.0 | -7.8 | -7.7 | 6.7 | 8.3 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
|---|---|---|---|
|
Science 37 Holdings (SNCE)
| -35.7 | -96.7 | 16.9 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Science 37 Holdings (SNCE)
|
5.8 | 34.7 | 60.3 | -123.5 | -0.1 | -190.3 | -- | 0.7 |
| 48.3 | 3,527.9 | 970.0 | -179.0 | -16.5 | -98.4 | -- | 18.6 | |
| 156.9 | 26,443.8 | 4,215.6 | 263.7 | 8.2 | 83.7 | 103.2 | 35.7 |
Shareholding Pattern
View DetailsAbout Science 37 Holdings (SNCE)
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and... sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC. Read more
-
CEO & Director
Mr. David Coman
-
CEO & Director
Mr. David Coman
-
Headquarters
Research Triangle Park, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Science 37 Holdings (SNCE)
What is the current share price of Science 37 Holdings Inc (SNCE) Today?
The share price of Science 37 Holdings Inc (SNCE) is $5.75 (NASDAQ) as of 22-Mar-2024 09:30 EDT. Science 37 Holdings Inc (SNCE) has given a return of -69.82% in the last 3 years.
What is the current PB & PE ratio of Science 37 Holdings Inc (SNCE)?
Since, TTM earnings of Science 37 Holdings Inc (SNCE) is negative, P/E ratio is not available.
The P/B ratio of Science 37 Holdings Inc (SNCE) is 0.67 times as on 22-Mar-2024, a 90 discount to its peers’ median range of 6.88 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.05
|
0.03
|
|
2021
|
-0.77
|
-0.23
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2022
|
-0.05
|
0.03
|
What is the 52 Week High and Low of Science 37 Holdings Inc (SNCE)?
The 52-week high and low of Science 37 Holdings Inc (SNCE) are Rs -- and Rs -- as of 27-May-2026.
What is the market cap of Science 37 Holdings Inc (SNCE)?
Science 37 Holdings Inc (SNCE) has a market capitalisation of $ 35 Mln as on 22-Mar-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in Science 37 Holdings Inc (SNCE)?
Before investing in Science 37 Holdings Inc (SNCE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.